DOREEN THOMAS-PAYNE: Open Payments
NPI 1285235663 · FLOURTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 49 payments from 11 companies in 2025. Trend: 2023 $285 · 2024 $462 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $445 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $78 |
| Janssen Pharmaceuticals, Inc | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Alkermes, Inc. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Almatica Pharma LLC | 1 | $22 |
Products named: VRAYLAR, CAPLYTA, REXULTI, SPRAVATO, ARISTADA, COBENFY, FANAPT, Qelbree.
Industry payments across PA — which companies pay providers there.
